Table 3

Estimates of completeness of each source (model 7)
Strata Total DOVIH EPF LaboVIH
<a onClick="popup('http://www.biomedcentral.com/1471-2334/12/251/mathml/M12','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2334/12/251/mathml/M12">View MathML</a> (95% CI) Nobs Compl(%) (95% CI) Nobs Compl(%) (95% CI) Nobs Compl(%) (95% CI) Nobs Compl(%) (95% CI)
Year of diagnosis
2003 107 (72.4;142.7) 60 55.8 (42.0:82.9) 30 27.9 (21.0;41.4) 28 26.0 (19.6:38.7) 30 27.9 (21.0;41.4)
2004 99 (68.9;129.4) 59 59.5 (45.6;85.7) 35 35.3 (27.0;50.8) 32 32.3 (24.7;46.5) 35 35.3 (27.0;50.8)
2005 91 (62.4;120.9) 53 57.8 (43.8;85.0) 27 29.5 (22.3;43.3) 27 29.5 (22.3;43.3) 34 37.1 (28.1;54.5)
2006 88 (55.4;121.8) 44 49.7 (36.1;79.4) 18 20.3 (14.8;32.5) 14 15.8 (11.5;25.3) 30 33.9 (24.6;54.2)
Place of birth
France 152 (100.3;204.9) 86 56.4 (42.0;85.7) 37 24.2 (18.1;36.9) 47 30.8 (22.9;46.8) 55 36.0 (26.8;54.8)
Foreign country 234 (158.9;309.9) 130 55.5 (42.0;81.8) 73 31.1 (23.6;45.9) 54 23.0 (17.4;34.0) 74 31.6 (23.9;46.6)
Region of diagnosis
Paris area 198 (154.7;241.4) 139 70.2 (57.6;89.9) 79 39.9 (32.7;51.1) 79 39.9 (32.7;51.1) 82 41.4 (34.0;53.0)
Other regions 188 (101.0;276.8) 77 40.8 (27.8;76.2) 31 16.4 (11.2;30.7) 22 11.6 (7.9;21.8) 47 24.9 (17.0;46.5)
Total 387 (271;503) 216 55.8 (42.9;79.7) 110 28.4 (21.9;40.1) 101 26.1 (20.1;37.3) 129 33.3 (25.6;47.6)

DOVIH: Mandatory HIV case reporting; EPF: ANRS French Perinatal Cohort; LaboVIH: Laboratory surveillance of HIV testing activity.

<a onClick="popup('http://www.biomedcentral.com/1471-2334/12/251/mathml/M13','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2334/12/251/mathml/M13">View MathML</a>: Estimate of the number of diagnoses; Nobs: Number of diagnoses observed; Compl: Completeness; 95% CI: 95% confidence interval for completeness.

Héraud-Bousquet et al.

Héraud-Bousquet et al. BMC Infectious Diseases 2012 12:251   doi:10.1186/1471-2334-12-251

Open Data